Apoquel is a drug owned by ZOETIS INC. It is protected by 5 US drug patents filed from 2019 to 2033. Out of these, 3 patents are active and 2 patents have expired. Details of Apoquel’s patents and their expiration are given below.
Exclusivity Information
Apoquel holds 1 exclusivity out of which 1 has expired. Details of Apoquel's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCE | May 14, 2018 |
About Apoquel
Apoquel is a drug
owned by ZOETIS INC.
Apoquel uses
Oclacitinib as the active
ingredient.
Active Ingredient:
Apoquel uses
Oclacitinib as the active ingredient.
Check out other Drugs and Companies using
Oclacitinib ingredient.